Railkar, Radha
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChat
Most cited papers
- Verified
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine
Cervical Cancer and HPV ResearchGenital Health and Disease
Cited by 1,886
- Verified
Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
Fourati, S., Cristescu, R., Loboda, A., Talla, A., Filali, A., Railkar, R., Schaeffer, A. K., Favre, D., Gagnon, D., Peretz, Y., et al. (2016) · Nature Communications
Immune responses and vaccinationsHepatitis B Virus Studies
Cited by 183
- Verified
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
Aliprantis, A. O., Shaw, C. A., Griffin, P., Farinola, N., Railkar, R. A., Cao, X., Liu, W., Sachs, J. R., Swenson, C. J., Lee, H., et al. (2021) · Human Vaccines & Immunotherapeutics
Respiratory viral infections researchSARS-CoV-2 and COVID-19 Research
Cited by 149
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free